Immucell Corp (ICCC) Dividend History

Immucell Corporation (ICCC) specializes in the development, manufacture, and marketing of dairy and beef cattle diagnostics, primarily focusing on products that enhance reproductive health and management in livestock. The company's offerings include herd management tools and diagnostic tests designed to improve productivity and efficiency for dairy and beef producers.

56 Evergreen Dr, Portland, ME, 04103
Phone: (207) 878-2770
Website:

Dividend History

Immucell Corp currently does not pay dividends

Company News

  • PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday - Benzinga

    The article discusses several stocks to watch heading into Wednesday, including PriceSmart, Kura Sushi, Manchester United, ImmuCell, and AZZ Inc. It provides details on the expected earnings and stock price movements for these companies.

    Benzinga
    Featured Companies: AZZ KRUS MANU PSMT
  • ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®

    PORTLAND, Maine , June 05, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today provided a regulatory update on the status of its product development initiative for Re-Tain®.

    GlobeNewswire Inc.
  • ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

    PORTLAND, Maine, June 04, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced that its 2024 Annual Meeting of Stockholders (the “Annual Meeting”) will be conducted virtually on Thursday, June 13, 2024, at 9:30 AM ET, as previously disclosed in its Proxy Statement filed with the Securities and Exchange Commission (“SEC”) on April 26, 2024.

    GlobeNewswire Inc.
  • ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024

    Conference Call Scheduled for Wednesday, May 15, 2024 at 9:00 AM ET Conference Call Scheduled for Wednesday, May 15, 2024 at 9:00 AM ET

    GlobeNewswire Inc.
  • ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024

    PORTLAND, Maine, April 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited sales results for the first quarter of 2024, which ended March 31, 2024.

    GlobeNewswire Inc.
Dividend data last updated 06/07/2025 19:48:38 UTC